Additional Details

  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Pulmonary Associates of Richmond, Inc.
    Richmond VA. 23230
    View Details

  • H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

    NIEHS Clinical Research Unit (CRU)
    Research Triangle Park NC. 27709
    View Details

  • The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

    University of Virginia
    Charlottesville VA. 22908
    View Details

  • Move With Air: Physiological Response Assessment

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • Move With Air: Exercise Training Study

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    UC Davis
    Sacremento CA. 95817
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    University of Minnesota
    Minneapolis MN. 55455
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    The Medical Research Group, Inc.
    Fresno CA. 93720
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    University of Cincinnati Health
    Cincinnati OH. 45219
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    National Jewish Health
    Denver CO. 80206
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    University of Rochester
    Rochester NY. 14627
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Advent Health
    Orlando FL. 32803
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Tampa General Hospital Center of Research Excellence
    Tampa FL. 33606
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Medical University of South Carolina
    Charleston SC. 29425
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    UCSF
    San Francisco CA. 94143
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Houston Methodist
    Houston TX. 77030
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    UCLA Westwood
    Los Angeles CA. 90095
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    NYU Langone Medical Center
    New York NY. 10016
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    University of Utah
    Salt Lake City UT. 84112
    View Details